Literature DB >> 22514373

Update: Intravenous immune globulin in children.

.   

Abstract

Entities:  

Year:  1995        PMID： 22514373      PMCID： PMC3327904          DOI： 10.1155/1995/198693

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  20 in total

Review 1.  Intravenous immunoglobulin: use in pediatric bone marrow transplantation.

Authors:  J T Casper; G Sedmak; R E Harris; D R Carrigan; L A Baxter-Lowe; R C Ash
Journal:  Semin Hematol       Date:  1992-07       Impact factor: 3.851

2.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

3.  Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.

Authors: 
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

4.  Recommended timing of routine measles immunization for children who have recently received immune globulin preparations. American Academy of Pediatrics Committee on Infectious Diseases.

Authors: 
Journal:  Pediatrics       Date:  1994-04       Impact factor: 7.124

5.  Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.

Authors:  C A Edwards; M P Piet; S Chin; B Horowitz
Journal:  Vox Sang       Date:  1987       Impact factor: 2.144

6.  Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors.

Authors:  E A Sekul; E J Cupler; M C Dalakas
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

7.  Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates.

Authors:  J Kinney; L Mundorf; C Gleason; C Lee; T Townsend; R Thibault; A Nussbaum; H Abby; R Yolken
Journal:  Am J Dis Child       Date:  1991-11

8.  A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

Authors:  A A Fanaroff; S B Korones; L L Wright; E C Wright; R L Poland; C B Bauer; J E Tyson; J B Philips; W Edwards; J F Lucey
Journal:  N Engl J Med       Date:  1994-04-21       Impact factor: 91.245

9.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.

Authors:  D J Winston; W G Ho; K Bartoni; R E Champlin
Journal:  Bone Marrow Transplant       Date:  1993-09       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.